Potentially first-in-class oral TNIK inhibitor advances into late-stage development after milestones marked by vital peer-reviewed papers: the discovery-to-clinic journey in Nature Biotechnology, and ...
ExxonMobil Testing Portfolio Manager Rafael Paura Vieira Fernandes outlines how to maintain oil and gas transformations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results